Global Healthcare Gamification Market Estimated to Hit $47,281.5 Million and Grow with a Significant CAGR of 11.9% from 2019 to 2026 – Exclusive Report [120 Pages] By Research Dive
June 29, 2021 09:00 ET
|
Research Dive
New York, USA, June 29, 2021 (GLOBE NEWSWIRE) -- A latest report on the global healthcare gamification market has been added by Research Dive to its offerings. As per the report, the market is...
Exavir Therapeutics announces the publication of preclinical data for the ultra-long-acting integrase inhibitor XVIR-110 in Nature Communications, affirming its unique pharmacokinetic profile and potential as a best-in-class yearly antiretroviral
June 08, 2021 07:00 ET
|
Exavir Therapeutics
With a single administration, XVIR-110, a nano-formulated prodrug integrase inhibitor, provided year-long plasma drug levels sufficient for HIV treatment and prophylaxis in animal models Studies...
Codex DNA Expands End-to-End Automated Synthetic Biology Workstation Enabling High Throughput Synthesis from DNA Sequence to Biologically Active mRNA
April 27, 2021 10:00 ET
|
Codex
San Diego, CA, April 27, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, today...
Brain Scientific Announces Collaboration with JelikaLite in New Clinical Trial
March 16, 2021 08:30 ET
|
Brain Scientific Inc.
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, announces a collaboration...
Milestone Scientific to Present at the Q1 Virtual Investor Summit
March 12, 2021 07:00 ET
|
Milestone Scientific Inc.
ROSELAND, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provides virtually...
Interpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of Florida
January 28, 2021 09:15 ET
|
Interpace Biosciences, Inc.
In-network status for ThyGeNEXT® and ThyraMIR® with State’s Largest Payer PARSIPPANY, NJ, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) announced today that the...
Cocrystal Pharma Selects Lead Compound for Further Development Against Coronaviruses
December 22, 2020 08:30 ET
|
Cocrystal Pharma, Inc.
CDI-45205 holds potential as a therapeutic and as a prophylactic to protect against coronavirus transmission, including SARS-CoV-2 BOTHELL, Wash., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cocrystal...
TeneoFour’s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals
November 16, 2020 11:00 ET
|
TeneoBio, Inc
NEWARK, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Teneobio, Inc. and its affiliate TeneoFour, Inc. announced today a Nature Metabolism publication...
BetterLife Pharma Receives Approval from Altum Pharmaceuticals Inc. Shareholders to Complete Merger
July 30, 2020 07:30 ET
|
BetterLife Pharma
Vancouver, July 30, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT), an emerging biotechnology company with proprietary...
BetterLife CEO Discusses Synairgen’s Interferon Breakthrough Treatment
July 28, 2020 08:00 ET
|
BetterLife Pharma
New York City, July 28, 2020 (GLOBE NEWSWIRE) -- The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company currently preparing a potential...